SecSonar.com

Plus Therapeutics, Inc. (PSTV)

Plus Therapeutics, Inc. at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

Plus Therapeutics, Inc. (PSTV) is a Biotechnology company based in US with a market capitalization of $14.4M. Revenue declined 10.5% year-over-year and free cash flow was negative at -$20.8M. This page tracks PSTV's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

US · 21 employees · IPO Jul 11, 2001

Valuation

Valuation & price

$5.25 · as of May 17, 2026 · -76.4% vs 52w high

—

P/E ratio

Latest-FY diluted EPS

3.60

P/B ratio

Market cap ÷ book equity

—

Dividend yield

Price — last 12 months

$22.24$12.58$2.92Jul 25Dec 25Jul 26Jul 7, 25$7.51Jul 9, 25$8.82Jul 11, 25$8.99Jul 15, 25$7.93Jul 17, 25$9.57Jul 21, 25$9.60Jul 23, 25$12.25Jul 25, 25$13.25Jul 29, 25$13.20Jul 31, 25$12.08Aug 4, 25$18.48Aug 6, 25$19.00Aug 11, 25$17.50Aug 13, 25$14.36Aug 15, 25$15.70Aug 19, 25$13.08Aug 21, 25$12.08Aug 25, 25$12.13Aug 27, 25$12.37Aug 29, 25$11.40Sep 3, 25$11.50Sep 5, 25$12.29Sep 9, 25$12.33Sep 11, 25$11.75Sep 16, 25$10.63Sep 18, 25$10.78Sep 22, 25$10.58Sep 24, 25$10.11Sep 26, 25$15.43Sep 30, 25$17.09Oct 2, 25$17.06Oct 6, 25$22.24Oct 8, 25$18.66Oct 10, 25$17.43Oct 14, 25$17.58Oct 16, 25$15.35Oct 21, 25$15.49Oct 23, 25$15.87Oct 27, 25$15.06Oct 29, 25$13.54Oct 31, 25$13.58Nov 4, 25$12.73Nov 6, 25$12.85Nov 10, 25$14.02Nov 12, 25$13.93Nov 14, 25$12.79Nov 18, 25$12.75Nov 20, 25$12.21Nov 25, 25$14.02Nov 28, 25$15.25Dec 2, 25$14.75Dec 4, 25$16.38Dec 8, 25$15.75Dec 10, 25$16.81Dec 12, 25$17.10Dec 16, 25$15.93Dec 18, 25$13.79Dec 22, 25$14.87Dec 24, 25$14.30Dec 29, 25$13.69Jan 2, 26$13.88Jan 6, 26$14.03Jan 8, 26$14.63Jan 12, 26$12.25Jan 14, 26$7.26Jan 16, 26$7.20Jan 21, 26$7.30Jan 23, 26$6.78Jan 27, 26$5.98Jan 29, 26$6.13Feb 2, 26$6.05Feb 4, 26$6.05Feb 9, 26$6.35Feb 11, 26$6.78Feb 13, 26$6.88Feb 18, 26$7.07Feb 20, 26$6.88Feb 24, 26$7.00Feb 26, 26$8.11Mar 2, 26$7.49Mar 4, 26$7.72Mar 6, 26$7.22Mar 10, 26$7.56Mar 12, 26$7.37Mar 17, 26$6.25Mar 19, 26$6.03Mar 23, 26$6.11Mar 25, 26$6.15Mar 27, 26$5.75Mar 31, 26$4.06Apr 2, 26$3.56Apr 7, 26$2.92Apr 9, 26$3.92Apr 13, 26$5.41Apr 15, 26$5.65Apr 17, 26$6.39Apr 22, 26$7.62Apr 24, 26$6.60Apr 28, 26$5.95Apr 30, 26$6.14May 4, 26$6.30May 6, 26$6.00May 8, 26$6.12May 12, 26$5.85May 14, 26$5.76May 18, 26$5.84May 20, 26$6.43May 22, 26$6.59May 28, 26$6.43Jun 1, 26$5.70Jun 3, 26$5.42Jun 5, 26$5.41Jun 9, 26$5.50Jun 11, 26$5.42Jun 15, 26$4.85Jun 17, 26$4.31Jun 22, 26$3.98Jun 24, 26$3.96Jun 26, 26$4.20Jul 2, 26$3.98
$2.9252-week range$22.24
Loading valuation history…

Fundamentals

Key fundamentals

$14.4M

Market cap

-10.5%

Revenue growth (YoY)

91.5%

Gross margin

-$20.8M

Free cash flow (USD)

-$7.9M

Net debt

Net cash position

1071.7%

Share dilution

1/5

Graham criteria passed

Defensive-investor screen

Healthcare

Sector

Trajectory

Long-term trends

Revenue by year

2016 → 2025

FY 2016$11.4MFY 2017$6.4MFY 2018$3.0MFY 2019$7.0MFY 2020$303.0KFY 2021$0.00FY 2022$224.0KFY 2023$4.9MFY 2024$5.8MFY 2025$5.2M
$11.4M$5.2M

Free cash flow by year

2016 → 2025

FY 2016$-19.6MFY 2017$-19.6MFY 2018$-12.1MFY 2019$-6.0MFY 2020$-8.9MFY 2021$-10.4MFY 2022$-13.7MFY 2023$-13.0MFY 2024$-10.7MFY 2025$-20.8M
-$19.6M-$20.8M

Gross margin by year

2022 → 2025

FY 2022-217.9%FY 2023-97.2%FY 202485.4%FY 202591.5%
-217.9%91.5%

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

0

Insider buys · 90 days

0

Insider sells · 90 days

Earnings

Last reported: May 15, 2026 (EPS $-1.05)

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • FinancingSecurities RegistrationJun 5, 2026Filing
  • 8-K eventEquity Distribution AgreementJun 5, 2026Filing
  • FinancingSecurities RegistrationJun 2, 2026Filing
  • 8-K eventEarnings ReleaseMay 15, 2026Filing
  • Quarterly report10-Q FiledMay 15, 2026Filing
  • 8-K eventAnnual Meeting ResultsMay 15, 2026Filing
  • 8-K eventRegained Nasdaq ComplianceApr 21, 2026Filing
  • 8-K eventExecutive Employment AgreementApr 9, 2026Filing
  • 8-K eventOrphan Drug DesignationApr 8, 2026Filing
  • 8-K eventReverse Stock SplitApr 2, 2026Filing

Questions

Frequently asked questions

What is Plus Therapeutics, Inc.'s market cap?

Plus Therapeutics, Inc. (PSTV) has a market capitalization of $14.4M.

What is PSTV's P/E ratio?

A meaningful P/E ratio is not available for PSTV — the company's latest fiscal-year earnings per share is zero, negative, or not yet cached.

What is PSTV's price-to-book (P/B) ratio?

PSTV trades at 3.60 times book value per share.

When did Plus Therapeutics, Inc. last report earnings?

PSTV last reported earnings on May 15, 2026; the next date is not yet scheduled.

Are insiders buying PSTV stock?

SEC Form 4 filings show no open-market insider buys at Plus Therapeutics, Inc. in the last 90 days (0 sells).

Same arena

Related companies in Biotechnology

TAOX

TAO Synergies Inc.

$14M

CYCN

Cyclerion Therapeutics, Inc.

$13.6M

TRAW

Traws Pharma, Inc.

$13.4M

GDTC

CytoMed Therapeutics Limited

$13.4M

LGVN

Longeveron Inc.

$15.4M

LPCN

Lipocine Inc.

$13.2M

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.